Correlation Between Aileron Therapeutics and Cocrystal Pharma
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Cocrystal Pharma, you can compare the effects of market volatilities on Aileron Therapeutics and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Cocrystal Pharma.
Diversification Opportunities for Aileron Therapeutics and Cocrystal Pharma
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aileron and Cocrystal is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Cocrystal Pharma go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Cocrystal Pharma
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.19 times less risky than Cocrystal Pharma. The stock trades about -0.56 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 176.00 in Cocrystal Pharma on September 13, 2024 and sell it today you would earn a total of 10.00 from holding Cocrystal Pharma or generate 5.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. Cocrystal Pharma
Performance |
| Timeline |
| Aileron Therapeutics |
| Cocrystal Pharma |
Aileron Therapeutics and Cocrystal Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Cocrystal Pharma
The main advantage of trading using opposite Aileron Therapeutics and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.| Aileron Therapeutics vs. Puma Biotechnology | Aileron Therapeutics vs. Iovance Biotherapeutics | Aileron Therapeutics vs. Sarepta Therapeutics | Aileron Therapeutics vs. Day One Biopharmaceuticals |
| Cocrystal Pharma vs. RenovoRx | Cocrystal Pharma vs. Tempest Therapeutics | Cocrystal Pharma vs. Ikena Oncology | Cocrystal Pharma vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |